SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001047469-17-003070
Filing Date
2017-04-28
Accepted
2017-04-28 17:09:24
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 a2231971zf-3.htm F-3 618985
2 EX-1.2 a2231971zex-1_2.htm EX-1.2 319000
3 EX-4.4 a2231971zex-4_4.htm EX-4.4 411994
4 EX-4.5 a2231971zex-4_5.htm EX-4.5 434060
5 EX-5.1 a2231971zex-5_1.htm EX-5.1 76488
6 EX-5.2 a2231971zex-5_2.htm EX-5.2 22509
7 EX-23.1 a2231971zex-23_1.htm EX-23.1 4019
8 EX-23.2 a2231971zex-23_2.htm EX-23.2 2725
9 G118852KQI001.JPG g118852kqi001.jpg GRAPHIC 7612
10 G432108.JPG g432108.jpg GRAPHIC 24893
11 G493348.JPG g493348.jpg GRAPHIC 26782
12 G852078.JPG g852078.jpg GRAPHIC 30729
  Complete submission text file 0001047469-17-003070.txt   2015360
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: F-3 | Act: 33 | File No.: 333-217555 | Film No.: 17796923
SIC: 2834 Pharmaceutical Preparations